Get the Stockscreener App
0.60
1.59%
0.0094
After Hours:
.59
-0.01
-1.67%
Xortx Therapeutics Inc stock is traded at $0.60, with a volume of 23,485.
It is up +1.59% in the last 24 hours and up +10.01% over the past month.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.
See More
Previous Close:
$0.5906
Open:
$0.61
24h Volume:
23,485
Relative Volume:
0.01
Market Cap:
$4.18M
Revenue:
-
Net Income/Loss:
$-736.70K
P/E Ratio:
-60.00
EPS:
-0.01
Net Cash Flow:
$-4.14M
1W Performance:
-1.64%
1M Performance:
+10.01%
6M Performance:
-30.23%
1Y Performance:
-46.43%
1-Day Range:
$0.5919
$0.612
1-Week Range:
$0.58
$0.6201
52-Week Range:
$0.515
$1.79
Xortx Therapeutics Inc Stock (XRTX) Company Profile
Compare XRTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XRTX
Xortx Therapeutics Inc
|
0.60 | 4.11M | 0 | -736.70K | -4.14M | -0.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.20 | 113.51B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
767.96 | 78.69B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.23 | 52.32B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.99 | 52.15B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
174.84 | 35.52B | 447.02M | -1.18B | -906.14M | -6.1812 |
Xortx Therapeutics Inc Stock (XRTX) Latest News
Will XORTX Therapeutics Inc. stock attract more institutional investors2025 Bull vs Bear & Weekly Momentum Stock Picks - DonanımHaber
XORTX Therapeutics Inc. (XRTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Will XORTX Therapeutics Inc. stock beat EPS estimates2025 Technical Patterns & Risk Adjusted Buy/Sell Alerts - Улправда
Is XORTX Therapeutics Inc. stock positioned well for digital economy2025 Top Gainers & Consistent Profit Trading Strategies - Улправда
Aug Analyst Calls: Will XORTX Therapeutics Inc stock attract ESG investorsJuly 2025 Chart Watch & Growth Focused Stock Reports - BỘ NỘI VỤ
XORTX Therapeutics Announces US$1.1 Million Direct Offering - MSN
XORTX Therapeutics (XRTX) Stock Analysis Report | Financials & Insights - Benzinga
Can XORTX Therapeutics Inc. (ANUA) stock deliver strong annual returnsMarket Risk Analysis & Safe Entry Zone Tips - Newser
Is XORTX Therapeutics Inc. stock a defensive play in 2025Weekly Earnings Recap & Stepwise Swing Trade Plans - Newser
Is XORTX Therapeutics Inc. (ANUA) stock a buy for dividend portfoliosEarnings Risk Report & Free Real-Time Volume Trigger Notifications - Newser
Why XORTX Therapeutics Inc. (ANUA) stock could outperform next yearJuly 2025 Outlook & Daily Volume Surge Signals - Newser
Why XORTX Therapeutics Inc. stock could see breakout soonJuly 2025 Drop Watch & Accurate Buy Signal Alerts - Newser
Will XORTX Therapeutics Inc. stock deliver strong dividend growthWeekly Stock Report & High Accuracy Swing Trade Signals - Newser
How XORTX Therapeutics Inc. (ANUA) stock reacts to stronger dollar2025 Bull vs Bear & Risk Adjusted Buy and Sell Alerts - Newser
Can XORTX Therapeutics Inc. stock outperform in 2025 bull marketJuly 2025 Gainers & Capital Protection Trading Alerts - Newser
Is XORTX Therapeutics Inc. (ANUA) stock a buy before new product rolloutJuly 2025 Selloffs & Risk Controlled Daily Plans - Newser
Why XORTX Therapeutics Inc. (ANUA) stock could be top winner2025 Volume Leaders & Real-Time Volume Surge Alerts - moha.gov.vn
What drives XORTX Therapeutics Inc stock priceEconomic Data Impact & Low Entry Investment Growth - earlytimes.in
Will AI Trends Push Aditya Vision Limited Stock Even HigherLarge Cap Stability Picks & Explosive Profit Trading - earlytimes.in
XORTX Therapeutics Reports Q3 2025 Financial Results - MSN
Is XORTX Therapeutics Inc. stock attractive for hedge fundsPortfolio Update Report & Verified Technical Trade Signals - newser.com
Chart based exit strategy for XORTX Therapeutics Inc.2025 Key Lessons & Free Reliable Trade Execution Plans - newser.com
Is XORTX Therapeutics Inc. (ANUA) stock a top hedge fund pickJuly 2025 Sentiment & Verified Momentum Watchlists - newser.com
Heatmap analysis for XORTX Therapeutics Inc. and competitors2025 Earnings Surprises & Entry Point Strategy Guides - newser.com
What data driven models say about XORTX Therapeutics Inc.’s future2025 Market Trends & Long-Term Growth Stock Strategies - newser.com
Statistical indicators supporting XORTX Therapeutics Inc.’s strengthTrade Analysis Summary & Free Fast Gain Swing Trade Alerts - newser.com
Is XORTX Therapeutics Inc. stock cheap at current valuationWeekly Market Report & Daily Profit Maximizing Trade Tips - newser.com
Is XORTX Therapeutics Inc. stock trading near support levelsRisk Management & Weekly High Conviction Ideas - newser.com
Can XORTX Therapeutics Inc. stock attract ESG capital inflowsVolume Spike & Technical Pattern Alert System - newser.com
Will XORTX Therapeutics Inc. stock benefit from commodity pricesJuly 2025 Selloffs & Verified Trade Idea Suggestions - newser.com
[6-K] XORTX Therapeutics Inc. Current Report (Foreign Issuer) - Stock Titan
Xortx Therapeutics Inc Stock (XRTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):